The Americans are allowed to try monoclonal antibodies against covid on those people who have just become infected and who are more likely to die.
At least two pharmaceutical companies do this kind of thing.
They suggest treating those people who have a positive smear, but who are sitting at home.
First of all, it is necessary for people of age, with obesity, impaired immunity or with serious chronic diseases such as kidney failure and diabetes mellitus. That is, those who have a lot of chances to go to the hospital and never get out of there.
This is just one intravenous infusion of medication, which must be done as soon as possible after infection. Somewhere no later than 10 days from the onset of the first symptoms.
All this is done in a clinical trial. That is, they urgently approved it, but no one knows what will happen next.
Interestingly, people on artificial lung ventilation or even simply with a significant need for oxygen cannot be given new treatment. From it the prognosis worsens.
It's hard to imagine how all this can be organized. Well, approximately as if a person made a smear in the clinic, the smear turned out to be positive, the person is sick, but no longer than 10 days, he has there are indications listed, he still walks on foot, he is given a drip in the clinic, then in the same clinic after him they watch for some time so that he does not die from a sudden allergic reaction, and then he goes home, and then somehow they will follow him follow.
The result is something like without a magic injection, 15% of patients will rush to the hospital, and only 4% with an injection.
Personally, it is not entirely clear to me why people on mechanical ventilation are more likely to die from this drug. Both manufacturers very quickly stopped testing antibodies in critically ill patients.
In short, wait and see ...
